Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.

William Blair's assessment is that MariTide is an improvement on current obesity therapies with a profile that "will be ...

The Biden administration's eleventh hour move to expand Medicare coverage for anti-obesity drugs is likely to be popular ...

Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...